{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:44:26Z","timestamp":1773092666995,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10792-021-01961-4","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T09:03:14Z","timestamp":1627462994000},"page":"3921-3927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of effects of tamsulosin and silodosin on subfoveal choroidal thickness and pupil size diameters in patients with prostatic hyperplasia"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6505-9714","authenticated-orcid":false,"given":"Hatice Selen","family":"Kanar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut Taha","family":"Olcucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"issue":"5","key":"1961_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.21037\/tau.2019.10.01","volume":"8","author":"SD Lokeshwar","year":"2019","unstructured":"Lokeshwar SD, Harper BT, Webb E, Jordan A, Dykes TA, Neal DE Jr et al (2019) Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol 8(5):529\u2013539. https:\/\/doi.org\/10.21037\/tau.2019.10.01 (PubMed PMID: 31807429)","journal-title":"Transl Androl Urol"},{"issue":"5","key":"1961_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11255-015-1206-7","volume":"48","author":"A Alcaraz","year":"2016","unstructured":"Alcaraz A, Carballido-Rodr\u00edguez J, Unda-Urzaiz M, Medina-L\u00f3pez R, Ruiz-Cerd\u00e1 JL, Rodr\u00edguez-Rubio F et al (2016) Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment\u2014the QUALIPROST study. Int Urol Nephrol 48(5):645\u2013656","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1961_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4274\/eamr.galenos.2018.24855","volume":"36","author":"M Erko\u00e7","year":"2020","unstructured":"Erko\u00e7 M, Be\u015firo\u011flu H (2020) Comparison of bipolar TURP and monopolar TURP patients who underwent surgery due to benign prostatic hyperplasia. Eur Arc Med Res 36(1):8\u201311","journal-title":"Eur Arc Med Res"},{"issue":"4","key":"1961_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4274\/jus.galenos.2019.2612","volume":"6","author":"T Yonguc","year":"2019","unstructured":"Yonguc T, Sen V, Bozkurt HI, Aydin ME, Polat S, Yarimoglu S (2019) Impact of chronic constipation on lower urinary tract symptoms and uroflowmetry parameters in men. J Urolo Surg 6(4):308\u2013313. https:\/\/doi.org\/10.4274\/jus.galenos.2019.2612(PubMedPMID:WOS:000501997300007)","journal-title":"J Urolo Surg"},{"key":"1961_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5152\/tud.2019.88027","volume":"45","author":"TB Aydogan","year":"2019","unstructured":"Aydogan TB, Kaya E, Gazel E, Yalcin S, Aybal HC, Tunc L (2019) Impact of metabolic syndrome on pre- and postoperative parameters in patients undergoing a HoLEP surgery. Turkish J Urol 45:98\u2013103. https:\/\/doi.org\/10.5152\/tud.2019.88027 (PubMedPMID:WOS:000502637300017)","journal-title":"Turkish J Urol"},{"issue":"3","key":"1961_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5152\/tud.2019.82783","volume":"45","author":"C G\u00fcrb\u00fcz","year":"2019","unstructured":"G\u00fcrb\u00fcz C, Drake MJ (2019) Where can urodynamic testing help assess male lower urinary tract symptoms? Turkish J Urol 45(3):157","journal-title":"Turkish J Urol"},{"issue":"2","key":"1961_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4274\/jus.2015.272","volume":"2","author":"L Verim","year":"2015","unstructured":"Verim L, Y\u0131ld\u0131r\u0131m A, Pelteko\u011flu E, Ba\u015fok EK, Keskin SK, \u00c7anakc\u0131 C (2015) Evaluation of the lower urinary tract symptoms and erectile dysfunction with uroflowmetry, IPSS and IIEF questioniares. J Urol Surg 2(2):75\u201380","journal-title":"J Urol Surg"},{"issue":"8","key":"1961_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/j.1464-410X.2009.08497.x","volume":"104","author":"TL Yap","year":"2009","unstructured":"Yap TL, Brown C, Cromwell DA, Van Der Meulen J, Emberton M (2009) The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures. BJU Int 104(8):1104\u20131108. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08497.x","journal-title":"BJU Int"},{"issue":"1\u20132","key":"1961_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5489\/cuaj.3058","volume":"10","author":"M Bishr","year":"2016","unstructured":"Bishr M, Boehm K, Trudeau V, Tian Z, Dell\u2019Oglio P, Schiffmann J et al (2016) Medical management of benign prostatic hyperplasia: results from a population-based study. Can Urol Assoc J 10(1\u20132):55\u201359. https:\/\/doi.org\/10.5489\/cuaj.3058 (PubMed PMID: 26977208)","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"1961_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1254\/jphs.09R15FM","volume":"112","author":"MC Michel","year":"2010","unstructured":"Michel MC (2010) The Forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: \u03b1-blockers in the treatment of male voiding dysfunction\u2014How do they work and why do they differ in tolerability? J Pharmacol Sci 112(2):151\u2013157. https:\/\/doi.org\/10.1254\/jphs.09R15FM","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"1961_CR11","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1517\/14740338.2014.936376","volume":"13","author":"M Oelke","year":"2014","unstructured":"Oelke M, Gericke A, Michel MC (2014) Cardiovascular and ocular safety of \u03b11-adrenoceptor antagonists in the treatment of male lower urinary tract symptoms. Expert Opin Drug Saf 13(9):1187\u20131197. https:\/\/doi.org\/10.1517\/14740338.2014.936376","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"1961_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/sj.bjp.0704503","volume":"135","author":"F Suzuki","year":"2002","unstructured":"Suzuki F, Taniguchi T, Nakamura S, Akagi Y, Kubota C, Satoh M et al (2002) Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes. Br J Pharmacol 135(3):600\u2013608. https:\/\/doi.org\/10.1038\/sj.bjp.0704503 (PubMed PMID: 11834607)","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1961_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5173\/ceju.2017.1234","volume":"71","author":"A Lunacek","year":"2018","unstructured":"Lunacek A, Mohamad Al-Ali B, Radmayr C, Weber M, Horninger W, Findl O et al (2018) Ten years of intraoperative floppy iris syndrome in the era of \u03b1-blockers. Cent European J Urol 71(1):98\u2013104. https:\/\/doi.org\/10.5173\/ceju.2017.1234 (PubMed PMID: 29732214)","journal-title":"Cent European J Urol"},{"issue":"1","key":"1961_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4274\/tjo.10693","volume":"46","author":"T Sezer","year":"2016","unstructured":"Sezer T, Alt\u0131n\u0131\u015f\u0131k M, Koytak \u0130A, \u00d6zdemir MH (2016) The choroid and optical coherence tomography. Turk J Ophthalmol. 46(1):30\u20137. https:\/\/doi.org\/10.4274\/tjo.10693 (PubMed PMID: 27800255)","journal-title":"Turk J Ophthalmol."},{"issue":"2","key":"1961_CR15","first-page":"250","volume":"48","author":"K Shibata","year":"1995","unstructured":"Shibata K, Foglar R, Horie K, Obika K, Sakamoto A, Ogawa S et al (1995) KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol 48(2):250\u2013258","journal-title":"Mol Pharmacol"},{"issue":"4","key":"1961_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jcrs.2005.02.027","volume":"31","author":"DF Chang","year":"2005","unstructured":"Chang DF, Campbell JR (2005) Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 31(4):664\u2013673. https:\/\/doi.org\/10.1016\/j.jcrs.2005.02.027","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"1961_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/ijo.IJO_704_16","volume":"65","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Agrawal D (2017) Silodosin-associated intraoperative floppy iris syndrome. Indian J Ophthalmol 65(6):538\u2013539. https:\/\/doi.org\/10.4103\/ijo.IJO_704_16","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"1961_CR18","doi-asserted-by":"publisher","first-page":"e306-e","DOI":"10.1111\/aos.12549","volume":"93","author":"T Ipekci","year":"2015","unstructured":"Ipekci T, Akin Y, Hoscan B, Tunckiran A (2015) Intraoperative floppy iris syndrome associated with silodosin. Acta Ophthalmologica 93(4):e306-e. https:\/\/doi.org\/10.1111\/aos.12549","journal-title":"Acta Ophthalmologica"},{"issue":"9","key":"1961_CR19","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jcrs.2012.05.025","volume":"38","author":"T Goseki","year":"2012","unstructured":"Goseki T, Ishikawa H, Ogasawara S, Mashimo K, Nemoto N, Taguchi Y et al (2012) Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: possible mechanism of intraoperative floppy-iris syndrome. J Cataract Refract Surg 38(9):1643\u20131649. https:\/\/doi.org\/10.1016\/j.jcrs.2012.05.025","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"1961_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1211\/0022357043978","volume":"56","author":"PN Patil","year":"2004","unstructured":"Patil PN (2004) Parameters of drug antagonism: re-examination of two modes of functional competitive drug antagonism on intraocular muscles. J Pharm Pharmacol 56(8):1045\u20131053. https:\/\/doi.org\/10.1211\/0022357043978","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"1961_CR21","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1080\/02713683.2017.1359306","volume":"42","author":"M Dogan","year":"2017","unstructured":"Dogan M, Kutluksaman B, Keles I, Karalar M, Halat AO (2017) The effects of systemic alfuzosin and tamsulosin hydrochloride on choroidal thickness and pupil diameter sizes in cases with benign prostatic hyperplasia. Curr Eye Res 42(12):1638\u20131643. https:\/\/doi.org\/10.1080\/02713683.2017.1359306","journal-title":"Curr Eye Res"},{"issue":"10","key":"1961_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3109\/02713683.2014.971935","volume":"40","author":"E Sari","year":"2015","unstructured":"Sari E, Sogutlu Sari E, Yazici A, Ko\u00e7 A, Bulbul E, Koytak A et al (2015) The effect of systemic tamsulosin hydrochloride on choroidal thickness measured by enhanced depth imaging spectral domain optical coherence tomography. Curr Eye Res 40(10):1068\u20131072. https:\/\/doi.org\/10.3109\/02713683.2014.971935","journal-title":"Curr Eye Res"},{"issue":"2","key":"1961_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","volume":"29","author":"DL Nickla","year":"2010","unstructured":"Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29(2):144\u2013168. https:\/\/doi.org\/10.1016\/j.preteyeres.2009.12.002 (PubMed PMID: 20044062; PubMed Central PMCID: PMC2913695)","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1961_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1590\/s1677-5538.ibju.2019.0094","volume":"46","author":"MT \u00d6l\u00e7\u00fcc\u00fc","year":"2020","unstructured":"\u00d6l\u00e7\u00fcc\u00fc MT, Teke K, Yildirim K, To\u011fa\u00e7 M, I\u015f\u0131k B, Yilmaz YC (2020) Comparision effects of solifenacin, darifenacin, propiverine on ocular parameters in eyes: a prospective study. Int Braz J Urol 46(2):185\u2013193","journal-title":"Int Braz J Urol"},{"issue":"3","key":"1961_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0014-4835(02)00316-0","volume":"76","author":"A Reiner","year":"2003","unstructured":"Reiner A, Zagvazdin Y, Fitzgerald MEC (2003) Choroidal blood flow in pigeons compensates for decreases in arterial blood pressure. Exp Eye Res 76(3):273\u2013282. https:\/\/doi.org\/10.1016\/S0014-4835(02)00316-0","journal-title":"Exp Eye Res"},{"issue":"4","key":"1961_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00417-018-04216-8","volume":"257","author":"V Bouteleux","year":"2019","unstructured":"Bouteleux V, Kodjikian L, Mendes M, Agard E, Machkour-Bentaleb Z, El-Chehab H et al (2019) Increased choroidal thickness: a new feature to monitor age-related macular degeneration recurrence. Graefes Arch Clin Exp Ophthalmol 257(4):699\u2013707. https:\/\/doi.org\/10.1007\/s00417-018-04216-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"1961_CR27","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1172\/jci69076","volume":"123","author":"Y Chen","year":"2013","unstructured":"Chen Y, Palczewska G, Mustafi D, Golczak M, Dong Z, Sawada O et al (2013) Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration. J Clin Inves 123(12):5119\u201334. https:\/\/doi.org\/10.1172\/jci69076 (PubMed PMID: 24231350)","journal-title":"J Clin Inves"},{"issue":"2","key":"1961_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/jpet.117.245167","volume":"364","author":"T Orban","year":"2018","unstructured":"Orban T, Leinonen H, Getter T, Dong Z, Sun W, Gao S et al (2018) A combination of G protein-coupled receptor modulators protects photoreceptors from degeneration. J Pharmacol Exp Ther 364(2):207\u201320. https:\/\/doi.org\/10.1124\/jpet.117.245167 (PubMed PMID: 29162627)","journal-title":"J Pharmacol Exp Ther"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01961-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T09:04:13Z","timestamp":1636275853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01961-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1961"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01961-4","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"25 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hatice Selen Kanar declares that she has no conflict of interest. Mahmut Taha Olcucu declares that he has no conflict of interest. Ibrahim Ozdemir declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Local Ethical Committee approval number is: B.30.2ATA.0.01.00.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Research involving human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}